课题基金 / 基金详情

Purification of Cannabinoid Receptors Type 1 and 2

Purification of Cannabinoid Receptors Type 1 and 2
1 型和 2 型大麻素受体的纯化
批准号:
6647525
负责人:
NING LI
金额:
$25.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2004-07-31

项目摘要

项目成果

NING LI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Obtaining atomic resolution structures of membrane proteins such as G-protein coupled receptors (GPCRs) has been hampered by the difficulty to purify sufficient amounts of membrane protein. The only GPCR crystal structure available is bovine rhodopsin, which can be isolated in large amounts from bovine retina. We propose a novel approach to generate a source to purify large amounts of receptor, which could solve the bottleneck for GPCR crystallization. The covalently bound retinal of rhodopsin acts as an inverse agonist that maintains firmly the receptor in a very stable inactive state. Stability and homogeneity of the protein are key factors for the formation of highly ordered crystals that diffract at high resolution. The cannabinoid receptors (CBR) are the closest to rhodopsin in that when bound to the inverse agonist they exhibit a very stable inactive state, in this case associated with the G-protein, making them attractive GPCR targets for crystallization and structural elucidation. In Phase I we will test the feasibility of our novel source for receptor purification for CB1 and CB2 receptors, a prerequisite to a Phase II application for crystallization and structural elucidation of the CB1 and CB2 receptors, alone and complexed with G-protein in the inverse agonist bound state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of the matrix metalloproteinase in pemphigus autoantibody-mediated epidermal
Role of the matrix metalloproteinase in pemphigus autoantibody-mediated epidermal
Role of the matrix metalloproteinase in pemphigus autoantibody-mediated epidermal
Role of the matrix metalloproteinase in pemphigus autoantibody-mediated epidermal
海外基金